In a victory for the medical device industry, controversial preemption language was stripped from legislation reauthorizing the Medical Device User Fee and Modernization Act (MDUFMA) that passed the House Committee on Energy and Commerce June 21.
The committee also passed FDA-industry negotiated changes to the third-party inspection program before sending the bill to the full House for consideration, which is expected in July.
The preemption provision, which would have eliminated the FDA’s authority over state laws, threatened industry support of the overall legislation, according to AdvaMed. But the provision was removed after AdvaMed and lawmakers expressed concerns at a hearing earlier this month.
http://fdanews.com/newsletter/article?issueId=10360&articleId=95065
e martë, 26 qershor 2007
Abonohu te:
Posto komente (Atom)
Nuk ka komente:
Posto një koment